In light of this, three mutational signatures, including PolH-related SBS9, unknown SBS34, and the so-called artifact SBS56, were found to be determined by A3C-H/AICDA mRNA levels across both genomes and cancer types (Fig. 6). This evidence concerns the gene POLH and cancer.